计划状态
招聘阶段
允许先接受免疫治疗
是CRC 指导的试验
是标签
MSI-H/ MMRd、MSS/ MMRp评论
This is the “entry” trial to several cutting-edge immunotherapy cancer trials that take place at the NIH (National Institutes of Health), in Bethesda.
Clinical trials there are free of charge for the patients, and the NIH covers transportation and lodging costs for the patient after the first visit, if accepted as participant. Help with lodging for caregivers/family is also available, so people from all States may be able to enroll.
The “Surgery Branch”, despite its name, is focused on adoptive cells transfer with TILs (tumor infiltrating lymphocytes). His Chief since 1974 is Dr Steven Rosenberg, pioneer of the development of immunotherapy and gene therapy; he’s usually the Principal Investigator of the trials.
The easier way to find if there are some trials at the Surgery Branch, for which a patient may qualify (at the present or even later during treatment), is contacting this trial.
Researchers get the information/ genetic profile to determine if some of TIL (tumor infiltrating lymphocytes) trials could be right for the patient, for example:
https://clinicaltrials.gov/ct2/show/NCT01174121
| 地点 | 位置状态 |
|---|---|
| 美国 | |
|
美国国立卫生研究院临床中心 马里兰州贝塞斯达 20892 |
招聘 |
联系方式
纳入标准
* 纳入标准：
Age >= 18 years.
Patient suspected of having, or with biopsy proven, malignant disease.
Patient is able to understand and willing to sign a written informed consent document.
Patient is being evaluated for treatment on an NCI-SB protocols.
排除标准
排除标准：
Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.
